Prolyl Hydroxylase Inhibitors Protect from the Bone Loss in Ovariectomy Rats by Increasing Bone Vascularity

Cell Biochemistry and Biophysics

Volumn 69, Issue 1, 2014, Pages 141-149

  Liu, Xiaodong ^a   Tu, Yihui ^a   Zhang, Lianfang ^b   Qi, Jin ^b   Ma, Tong ^a   Deng, Lianfu ^b  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Estrogen; Hypoxia inducible factor; Osteoblasts; Ovariectomy; Prolyl hydroxylase inhibitor

Indexed keywords

RATTUS;

BONE DENSITY CONSERVATION AGENT; ESTROGEN; HIF1A PROTEIN, RAT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL HYDROXYLASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; BONE DENSITY; CYTOLOGY; DRUG EFFECTS; FEMALE; FEMUR; GENE EXPRESSION; GENETICS; METABOLISM; NEWBORN; OSTEOBLAST; OSTEOLYSIS; OVARIECTOMY; PREVENTION AND CONTROL; PRIMARY CELL CULTURE; RAT; SKULL; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; ESTROGENS; FEMALE; FEMUR; GENE EXPRESSION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OVARIECTOMY; PHOSPHATIDYLINOSITOL 3-KINASES; PRIMARY CELL CULTURE; PROLYL HYDROXYLASES; PROLYL-HYDROXYLASE INHIBITORS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SKULL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899460553     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9780-8     Document Type: Article

References (39)

1. Harada, S., & Rodan, G. A. (2003). Control of osteoblast function and regulation of bone mass. Nature, 423, 349-355.
2. Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003). Osteoclast differentiation and activation. Nature, 423, 337-342.
3. Burkhardt, R., Kettner, G., Bohm, W., Schmidmeier, M., Schlag, R., Frisch, B., et al. (1987). Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study. Bone, 8, 157-164.
4. Parfitt, A. M. (2000). The mechanism of coupling: A role for the vasculature. Bone, 2000(26), 319-323.
5. Vogt, M. T., Cauley, J. A., Kuller, L. H., & Nevitt, M. C. (1997). Bone mineral density and blood flow to the lower extremities: The study of osteoporotic fractures. Journal of Bone and Mineral Research, 12, 283-289.
6. Street, J. T., de Schrijver, K., Wang, J. H., Wu, Q. D., & Redmond, H. P. (2005). Hypoxia regulates the paracrine coupling of angiogenesis and bone formation. European Journal of Orthopaedic Surgery & Traumatology, 2005, 214-225.
7. Sanada, M., Taguchi, A., Higashi, Y., Tsuda, M., Kodama, I., Yoshizumi, M., et al. (2004). Forearm endothelial function and bone mineral loss in postmenopausal women. Atherosclerosis, 176, 387-392.
8. Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nature Reviews Cancer, 2003(3), 721-732.
9. Wang, Y., Wan, C., Deng, L., Liu, X., Cao, X., Gilbert, S. R., et al. (2007). The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. The Journal of Clinical Investigation, 117, 1616-1626.
10. Wan, C., Gilbert, S. R., Wang, Y., Cao, X., Shen, X., Ramaswamy, G., et al. (2008). Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proceedings to the National Academy of Science USA, 105, 686-691.
11. Zhao, Q., Shen, X., Zhang, W., Zhu, G., Qi, J., & Deng, L. (2012). Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss. Bone, 50, 763-770.
12. 2 sensing. Science, 292, 464-468.
13. Wang, G. L., & Semenza, G. L. (1993). Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood, 82, 3610-3615.
14. Warnecke, C., Griethe, W., Weidemann, A., Jurgensen, J. S., Willam, C., Bachmann, S., et al. (2003). Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. FASEB Journal, 17, 1186-1188.
15. Chau, N. M., Rogers, P., Aherne, W., Carroll, V., Collins, I., McDonald, E., et al. (2005). Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Cancer Research, 65, 4918-4928.
16. Shen, X., Wan, C., Ramaswamy, G., Mavalli, M., Wang, Y., Duvall, C. L., et al. (2009). Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. Journal of Orthopaedic Research, 27, 1298-1305.
17. Castoria, G., Migliaccio, A., Bilancio, A., Di, D. M., de Falco, A., Lombardi, M., et al. (2001). PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO Journal, 20, 6050-6059.
18. Cabodi, S., Moro, L., Baj, G., Smeriglio, M., Di, S. P., Gippone, S., et al. (2004). p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. Journal of Cell Science, 117, 1603-1611.
19. Honda, K., Sawada, H., Kihara, T., Urushitani, M., Nakamizo, T., Akaike, A., et al. (2000). Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. Journal of Neuroscience Research, 60, 321-327.
20. Yen, M. L., Su, J. L., Chien, C. L., Tseng, K. W., Yang, C. Y., Chen, W. F., et al. (2005). Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Molecular Pharmacology, 68, 1061-1073.
21. Tivesten, A., Moverare-Skrtic, S., Chagin, A., Venken, K., Salmon, P., Vanderschueren, D., et al. (2004). Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats. Journal of Bone and Mineral Research, 19, 1833-1839.
22. Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., et al. (1987). Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. Journal of Bone and Mineral Research, 2, 595-610.
23. Shepherd, B. R., Chen, H. Y., Smith, C. M., Gruionu, G., Williams, S. K., & Hoying, J. B. (2004). Rapid perfusion and network remodeling in a microvascular construct after implantation. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 898-904.
24. Kennedy, J. M., & Zochodne, D. W. (2002). Influence of experimental diabetes on the microcirculation of injured peripheral nerve: Functional and morphological aspects. Diabetes, 51, 2233-2240.
25. Parfitt, A. M. (1994). Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone. Journal of Cellular Biochemistry, 1994(55), 273-286.
26. Parfitt, A. M. (1998). Osteoclast precursors as leukocytes: Importance of the area code. Bone, 1998(23), 491-494.
27. Ding, W. G., Wei, Z. X., & Liu, J. B. (2011). Reduced local blood supply to the tibial metaphysis is associated with ovariectomy-induced osteoporosis in mice. Connective Tissue Research, 52, 25-29.
28. Richelson, L. S., Wahner, H. W., Melton, L. J., III, & Riggs, B. L. (1984). Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. New England Journal of Medicine, 311, 1273-1275.
29. Kang, D. H., Yu, E. S., Yoon, K. I., & Johnson, R. (2004). The impact of gender on progression of renal disease: Potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. American Journal of Pathology, 164, 679-688.
30. Sugino, N., Kashida, S., Takiguchi, S., Karube, A., & Kato, H. (2000). Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy. Journal of Clinical Endocrinology and Metabolism, 85, 3919-3924.
31. Kazi, A. A., Jones, J. M., & Koos, R. D. (2005). Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: Estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Molecular Endocrinology, 19, 2006-2019.
32. Kazi, A. A., & Koos, R. D. (2007). Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology, 2007, 2363-2374.
33. Pufe, T., Claasen, H., Scholz-Ahrens, K. E., Varoga, D., Drescher, W., Franke, A. T., et al. (2007). Influence of estradiol on vascular endothelial growth factor expression in bone: A study in Göttingen miniature pigs and human osteoblasts. Calcified Tissue International, 2007, 184-191.
34. Ivanova, T., Mendez, P., Garcia-Segura, L. M., & Beyer, C. (2002). Rapid stimulation of the PI3-kinase/Akt signalling pathway in developing midbrain neurones by oestrogen. Journal of Neuroendocrinology, 14, 73-79.
35. Sun, M., Paciga, J. E., Feldman, R. I., Yuan, Z., Coppola, D., Lu, Y. Y., et al. (2001). Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Research, 61, 5985-5991.
36. Lengyel, F., Vertes, Z., Kovacs, K. A., Kornyei, J. L., Sumegi, B., & Vertes, M. (2004). Expression and activation of Akt/protein kinase B in sexually immature and mature rat uterus. Journal of Steroid Biochemistry and Molecular Biology, 91, 285-288.
37. Guzelogli Kayisli, O., Kayisli, U. A., Luleci, G., & Arici, A. (2004). In vivo and in vitro regulation of Akt activation in human endometrial cells is estrogen dependent. Biology of Reproduction, 2004(71), 714-721.
38. Bain, S. D., Bailey, M. C., Celino, D. L., Lantry, M. M., & Edwards, M. W. (1993). High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse. Journal of Bone and Mineral Research, 8, 435-442.
39. Jeong, B. C., Kim, H. J., Bae, I. H., Lee, K. N., Lee, K. Y., Oh, W. M., et al. (2010). COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation. Bone, 46, 479-486.